期刊文献+

低分子肝素和S-腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的疗效对比 被引量:5

Comparison of curative effects of low-molecular-weight-heparin and S-adenosylmethionine in treatment of intrahepatic cholestasis of pregnancy
原文传递
导出
摘要 目的:比较和评估低分子肝素(LMWH)和S-腺苷蛋氨酸(SAMe)对妊娠期肝内胆汁淤积症(ICP)的治疗效果。方法:64例ICP患者,随机分成两组:A组用LMWH 1250 IU/d静脉滴注,5天为1疗程;B组用SAMe 1 000 mg/d,静脉滴注,疗程为7天,观察治疗效果。结果:两组患者治疗后瘙痒评分、血清总胆汁酸(TBA)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素(TB)及直接胆红素(DB)均有明显下降(P<0.05),下降程度两组间无统计学差异(P>0.05);两组间早产、羊水Ⅱ°~Ⅲ°粪染、胎儿窘迫、新生儿窒息(Apgar≤7)的发生率无明显差异;A组无围生儿死亡,B组有1例死胎。结论:LMWH能缓解ICP患者的症状,改善肝功能,其治疗作用与SAMe相似。 Objective:To compare and evaluate the curative effects of low-molecular-weight-heparin(LMWH) and S-adenosylmethionine(SAMe) in treatment of intrahepatic cholestasis of pregnancy(ICP).Methods:Sixty-four patients with ICP were selected,then they were randomly divided into two groups: the patients in group A were treated with intravenous drip of LMWH for 5 days,1 250 IU per day;while the patients in group B were treated with SAMe for 7 days,1 000 mg per day,the curative effects in the two groups were observed.Results:After treatment,pruritus score,the serum levels of total bile acid(TBA),alanine aminotransferase(ALT),aspartate aminotransferase(AST),total bilirubin(TB),and direct bilirubin(DB) in the two groups decreased significantly(P〈0.05),but there was no significant difference in the degree of decrease between the two groups(P〈0.05);there was no significant difference in the incidences of premature delivery,amniotic fluid contamination,fetal distress,and neonatal asphyxia(Apgar score≤7) between the two groups.No perinatal death occurred in group A,one dead fetus occurred in group B.Conclusion:LMWH can relieve symptoms of the patients with ICP and improve hepatic function,and its curative effect is similar to that of SAMe.
出处 《中国妇幼保健》 CAS 北大核心 2012年第13期1934-1936,共3页 Maternal and Child Health Care of China
基金 云南省科技厅-昆明医学院联合专项〔2008CD047〕资助
关键词 胆汁淤积症 肝内 妊娠 低分子肝素 S-腺苷蛋氨酸 Intrahepatic cholestasis of pregnancy Low-molecular-weight heparin S-adenosylmethionine
  • 相关文献

参考文献6

二级参考文献48

共引文献145

同被引文献70

  • 1罗陆萍,顾江红.茵陈制剂治疗妊娠期肝内胆汁淤积症的研究进展[J].中国中医药科技,2009,16(4):335-336. 被引量:10
  • 2胆汁淤积性肝病诊断治疗专家委员会.胆汁淤积性肝病诊断治疗专家共识2013[J].中华肝脏病杂志,2014,22(1). 被引量:26
  • 3王涛,刘淑芸,许良智,邢爱耘,刘关键.S-腺苷蛋氨酸改善妊娠肝内胆汁淤积症患者妊娠结局的评价[J].中国循证医学杂志,2005,5(2):130-135. 被引量:36
  • 4Angela K,Grone,James F,et al.Intrahepatic cholestasis of pregnancy [J].Neo Reviews ,2012,13(3) :e145-e150.
  • 5Maria B,Urszula KK,Agata KB.Influence of pharmacological treatment on selected parameters of intrahepatic cholestasis of pregnancy [J]. Ginekol Pol 2010 81(2):94-98.
  • 6European Association for the Study of the Liver.EASL clinical prac- tice guidelines:management of cholestatic liver diseases[J].J Hepatol. 2009,51 (2) :257-267.
  • 7Azzaroli F,Turco L,Lisotti A,et al.The pharmacological management of intrahepatic cholestasis of pregnancy [J].Curr Clin Pharmacol,2011,6(1):12-17.
  • 8Bacq Y,Sentilhes L,Reyes HB,et aLEfficacy of ursodeoxycholic acid in treating intrahepatic cho|estasis of pregnancy :a meta-analysis[J]. Gastroenterology, 2012,143 (6) : 1492-1501.
  • 9关于加强苯甲醇注射液管理的通知[Z].国食药监注[2005]263号.
  • 10国家食品药品监督管理局办公室关于组织开展含苯甲醇的注射液说明书检查的通知[Z].食药监办安函[2012]323号.

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部